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体 Big-ETから ET・1へ変換され、 ET-A及び ET-B受容体を介して血管収縮、心筋細胞肥大や線
維増生に機能する。










比して左室径の拡大を防止し、左室内圧の上昇を抑制した。不全心での SRCa2+-ATPase mRNA 
の upregulationに伴い、拡張能の指標である時定数タウの有意な短縮を認めた。線維化の指揮、で
ある collagen1、IImRNAの発現を低下させ、 picrosirius民d染色で定量したコラーゲン蓄積を抑
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9. SUM胤RYOF RESEARCH肥SULTS
1. Endothelin (ET)・1not only causes potent vasoconstriction but also leads to f1uid retention， which are both mediated by 
ETA and/or ETB receptors. We administered either the selective ETA receptor antagonist FR173651 (FR) or the mixed 
ETA/ETB receptor antagonist TAK-044 (TAK) to dogs with heart fClilure (HF) induced by rapid ventricular pacing. FR 
increased urinary excretion in association wi(h increased renal plasma flow (RPF) and glomerular filtration rate (GFR) with no 
significant changes in the frac;:tional reabsorption of water distally (FRWD). In contrast， despite increased GFR， TAK did not 
alter urine volume or RPF with significantly increased FRWD. The incremental magnitude of GFR and RPF induced by FR 
was significantly larger than that by T AK. These findings indica1e that ETB receptor activation may result in diuresis by renal 
vasodilatation and blunting water reabsorption in the distal tubules and collecting ducts. 
2. We administered K・8194，an orally active selective ET-B receptor antagonist， to dogs with HF. Plasma renin activity and 
aldosterone increased In both control and K8794 groups， however， levels in the K-8794 group were significantly lower than 
those in the control group. In the K・8794group， it was quite interesting to note that Na excretion and urine flow rate were 
higher than in the control group. Although Ei-B receptor antagonism possesses some hemodynamic disadvantages， it can 
successfully prevent body f1uid retention tl1rough the suppression of the activation of the renin-angiotensin-aldosterone 
system in dogs with HF. 
3. We examined the combination effects of an ET-converting enzyme inhibitoJ (FR901533) and an ACE inhibitor (enalapril) 
on changes in hemodynamics， the expression of molecular markers of HF and the histomorphometry compared with those of 
monotherapy in dogs with HF. Although there were no differences observed in LV ejection fraction， combination therapy of 
both inhibitors significantly decreased LV filing pressure， shortened the time constant of relaxation and upregulated the 
expression of sarcoplasmic reticulum Ca2←ATPase mRNA. The combination also decreased the exp陀 ssionof collagen type 
1 mRNA and cardiac tollagen deposits compared with those of monotherapy. Combining these two modes of enzyme 
inhibition may further improve L V diastolic dysfunction rather than systolic dysfunction， via modification of nitric oxide rele 
and Ca2+ handling as well as suppression of collagen accumulation in HF. 
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